MOLECULAR PARTNERS ADS/1 Cash Flow-to-Debt Ratio
MOLECULAR PARTNERS ADS/1 cash flow-to-debt ratio. MOLECULAR PARTNERS ADS/1 (6ML0) has a Cash Flow-to-Debt Ratio of -0.63x as of June 2026, meaning its operating cash flow of €-10.79 Million could theoretically repay -1% of its total liabilities (€17.15 Million) in one year. Check MOLECULAR PARTNERS ADS/1 cash flow quality index to evaluate the quality of earnings relative to operating cash generation.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Cash Flow-to-Debt Ratio of MOLECULAR PARTNERS ADS/1 (2021–2025)
Cash flow-to-debt ratio of MOLECULAR PARTNERS ADS/1 from 2021 to 2025. Historical debt coverage capacity for MOLECULAR PARTNERS ADS/1 across 5 annual periods. Check how aggressively does MOLECULAR PARTNERS ADS/1 reinvest cash to assess the company's total reinvestment commitment from operating cash flow.
MOLECULAR PARTNERS ADS/1 Cash Flow-to-Debt Ratio by Year (2021–2025)
MOLECULAR PARTNERS ADS/1 cash flow-to-debt ratio by year from 2021 to 2025. Year-by-year debt coverage analysis for MOLECULAR PARTNERS ADS/1. For the full cash flow conversion analysis, see 6ML0 cash flow conversion.
| Year | CF-to-Debt Ratio | Operating CF (EUR) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | -2.35x | €-51.26 Million | €21.77 Million | ▲ +32.9% |
| 2024 | -3.51x | €-59.25 Million | €16.89 Million | ▼ -30.3% |
| 2023 | -2.69x | €-59.01 Million | €21.92 Million | ▼ -161.5% |
| 2022 | 4.38x | €118.57 Million | €27.09 Million | ▲ +414.6% |
| 2021 | -1.39x | €-90.95 Million | €65.38 Million | — |